Warning letter
American Red Cross Transplantation Services: warning letter of Mar 11, 2004
FDA warning letter UCM146252 · Los Angeles District Office
Key facts
| Reference number | UCM146252 |
|---|---|
| Company | American Red Cross Transplantation Services |
| Subject | Human Tissue for Transplantation/Quality System Regulation/Adulterated |
| Issue date | Mar 11, 2004 |
| Posted date | Mar 11, 2004 |
| Issuing office | Los Angeles District Office |
| Product type | Biologics |
| CFR sections cited | 820 |
| Country | 3 |
| Inspection city | Lincoln |
| Inspection ZIP | 68508-1328 |
| Inspection start date | Nov 25, 2003 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- NAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: